Invitron Ltd

Invitron is developing a portable device that will perform rapid, accurate diagnostic tests using just a small finger prick of blood. The device is based on a next generation chemiluminescence technology that will deliver laboratory quality results at the point of care. In this project we are developing a test that measures the biomarker B-type natriuretic peptide, a blood protein which is elevated in patients with heart failure (HF) and which can provide a definitive diagnosis of HF. This will enable HF to be identified directly in GP practices, reducing the time to diagnosis from several days to just a few minutes. This will in turn facilitate earlier treatment where necessary and rapidly rule out patients without HF.

Invitron is developing a portable device that will perform rapid, accurate diagnostic tests using just a small finger prick of blood. The device is based on a next generation chemiluminescence technology that will deliver laboratory quality results at the point of care. In this project we are developing a test that measures the biomarker B-type natriuretic peptide, a blood protein which is elevated in patients with heart failure (HF) and which can provide a definitive diagnosis of HF. This will enable HF to be identified directly in GP practices, reducing the time to diagnosis from several days to just a few minutes. This will in turn facilitate earlier treatment where necessary and rapidly rule out patients without HF.